Century Communities, a leading U.S. homebuilder, will release its third quarter 2026 financial results after market close on October 28, 2026. The company will host a conference call the same day to discuss the results and recent developments, accessible via webcast and phone. This update is important for investors tracking the housing market and Century's performance across 16 states. The company is known for its quality homes and additional services like mortgage and insurance through subsidiaries.
Century Communities' upcoming third quarter 2026 earnings release is noted here alongside Pluang's snapshot of the U.S. Real Estate sector. As of October 7, 2026, 16 of 26 priced Real Estate-sector US stocks on Pluang rose while 10 fell. Notable movers include American Tower Corp (AMT) at USD 164.81 with a 1-day change of +1.57% and 100% buy order activity, Public Storage (PSA) at USD 285.90 up 1.51%, and Crown Castle International Corp (CCI) at USD 68.45 up 1.29%, with typical hold times ranging from 84 to 130 days.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
